Vergleich

Azasetron hydrochloride Europäischer Partner

ArtNr ALO-Y-100-10mg
Hersteller Alomone
CAS-Nr. 123040-16-4
Menge 10 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Kategorie
Typ Small Molecules
Format Lyophilized
Specific against other
Purity >98%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
5-HT3 receptors
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C.
Molecular Weight
386, 3
Manufacturer - Format
Lyophilized powder.
Short description
A Potent Antagonist of Serotonin-Gated Channels
Description
Y-25130 hydrochloride - A Potent Antagonist of Serotonin-Gated Channels
Reconstitution
100 mM in H2O. Centrifuge all product preparations before use (10000 x g 5 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
0.1-100 nM.
Activity
Azasetron hydrochloride is a potent 5-HT3 channel blocker with a Ki ~2.9 nM1.
Solubility
100 mM in H2O. Centrifuge all product preparations before use (10000 x g 5 min).
Bioassay tested
Yes
Chemical Name
N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1, 4-benzoxazine-8-carboxamide; hydrochloride.
Scientific Background
Azasetron hydrochloride (Y-25130 hydrochloride) is a potent 5-HT3 receptor antagonist. It selectively and competitively binds 5-HT3 receptors thereby blocking the serotonin binding site. Azasetron is classified as a derivative of benzamide. It has a different chemical structure from other 5-HT3 receptor blockers. The significant difference is found in the pharmacokinetic profiles resulting in a longer duration of action and a higher affinity for the 5-HT3 receptor1, 2. Azasetron has an IC50 value ~4.9x10-10 M4 and half life of 5.4 hours3.The 5-HT3 receptor subtype is a member of the Cys-loop ligand-gated cation channels which are expressed throughout the central and peripheral nervous systems and mediate a variety of physiological functions5.Azasetron is mostly administered orally and by I.V (60-70%) and excreted in the urine in an unmetabolized form. Orally-administered azasetron is shown to be absorbed and secreted by the saturable transport mechanism in the small intestine, resulting in good bioavailability (approximately 90%)2.5-HT3 receptor antagonists have been established in a number of clinical trials as effective agents in the management and prevention of nausea and vomiting caused by cancer chemotherapy as well as postoperative nausea and emesis after anesthesia and surgery1, 3.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10 mg
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 08.01.2026 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen